Key Highlights
- Chartis secures majority investment from Blackstone to support its continued growth in healthcare advisory.
- Blackstone’s investment will enhance Chartis’ strategic, digital, and technology offerings for healthcare clients.
- Audax Private Equity remains a key equity participant, continuing its support for Chartis.
- The partnership aims to expand Chartis’ capabilities and infrastructure in the evolving healthcare landscape.
Source: Business Wire
Notable Quotes
- “Blackstone shares our commitment to supporting industry leaders across the healthcare landscape as they strive to make care in the US more accessible, more affordable, more reliable, more equitable, and more human for patients and caregivers.” — Ken Graboys, CEO at Chartis
- “This investment will provide us with the resources to grow our organic offerings, expand our capabilities, and further enhance our infrastructure. We are excited about the future and confident that this partnership will help us enable our clients to reshape healthcare for the better.” — Greg Maddrey, President at Chartis
- “The increasing complexity of the healthcare landscape has only amplified the need for trusted partners like Chartis.” — Ram Jagannath, Senior Managing Director at Blackstone
SoHC's Take
This strategic investment by Blackstone marks a significant milestone for Chartis, reinforcing its position as a leading advisor in the US healthcare sector. By leveraging Blackstone’s extensive resources and expertise, Chartis is poised to expand its offerings and further strengthen its impact on healthcare transformation. The continued equity participation from Audax Private Equity underscores the strong foundation and growth trajectory that Chartis has established over the years. This partnership is expected to catalyze significant advancements in healthcare delivery, making it more accessible, affordable, and patient-centric.
Related

New Multiyear Agreement Between Ballad Health and Anthem in Virginia
Key Highlights Extended partnership ensures continued access for nearly 50,000 Anthem members in Virginia.Plans to expand digital connectivity to improve patient experiences and outcomes.Focus on innovative care delivery and value-based programs to address healthcare access and affordability.Source: Business Wire Notable Quotes "We are excited to extend our partnership with Ballad Health, which has been a…

Blackstone Partners with Moderna on $750M Flu Program Investment
Key Highlights Blackstone Life Sciences commits up to $750 million to fund Moderna's influenza vaccine program.The partnership highlights a strategic move to advance mRNA vaccines for respiratory illnesses.Moderna aims to launch multiple vaccine products in the coming years, with Blackstone's financing supporting late-stage studies.Potential milestones and royalties for BXLS upon successful development and commercialization of flu…

Blackstone Life Sciences Launches Uniquity Bio with $300M Investment
Key Highlights Uniquity Bio to advance solrikitug, a monoclonal antibody targeting TSLP.$300 million in capital from Blackstone for multiple indications.Phase 2 clinical trials to start for COPD and asthma.Partnership includes operational agility and scientific rigor.Source: Business Wire Notable Quotes “Our investment in Uniquity Bio illustrates Blackstone Life Sciences’ commitment to…